Pharmaceuticals
Biotechnology
Commercializing
Unitedstates
Development
Operating
M&A Advisory
Lazard
Full Credential Description
NovaBay Pharmaceuticals. United States. Announced Date 06/12/2012. Closed Date 11/12/2012. Deal value: $7m. Confidentially Marketed Public Offering. Industry: NovaBay Pharmaceuticals operates in the biotechnology and pharmaceuticals industry, focusing on developing and commercializing anti-infective products.